myocardial reperfusion injury
Showing 1 - 25 of >10,000
Reperfusion Injury, Myocardial Trial in Jakarta Pusat (Colchicine, Placebo (lactose))
Enrolling by invitation
- Reperfusion Injury, Myocardial
- Colchicine
- Placebo (lactose)
-
Jakarta Pusat, Jakarta, IndonesiaFakultas Kedokteran Universitas Indonesia
Feb 8, 2023
Myocardial Reperfusion Injury, Treatment Outcome, Prognosis Trial (Extracorporeal cardiac shock wave therapy(ECSW))
Not yet recruiting
- Myocardial Reperfusion Injury
- +3 more
- Extracorporeal cardiac shock wave therapy(ECSW)
- (no location specified)
Nov 12, 2022
Myocardial Reperfusion Injury Trial in Campinas (Pioglitazone 45 mg, Placebo)
Not yet recruiting
- Myocardial Reperfusion Injury
- Pioglitazone 45 mg
- Placebo
-
Campinas, SP, BrazilUniversity of Campinas
Mar 17, 2023
Myocardial Infarction, Reperfusion Injury, Myocardial Trial in Uxbridge (Transcoronary cooling and dilution, Standard of care)
Recruiting
- Myocardial Infarction
- Reperfusion Injury, Myocardial
- Transcoronary cooling and dilution
- Standard of care
-
Uxbridge, United KingdomHarefield Hospital
Nov 7, 2023
Myocardial Infarction, Myocardial Ischemia, Myocardial Injury Trial in Philadelphia
Recruiting
- Myocardial Infarction
- +10 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Sep 1, 2022
ST Elevation Myocardial Infarction, Inflammatory Response, Myocardial Reperfusion Injury Trial (Methylprednisolone, Isotonic
Not yet recruiting
- ST Elevation Myocardial Infarction
- +3 more
- Methylprednisolone
- Isotonic saline
- (no location specified)
Aug 4, 2022
Myocardial Reperfusion Injury, Hypoxia, Hyperoxia Trial (Hypoxic-hyperoxic preconditioning, Placebo)
Completed
- Myocardial Reperfusion Injury
- +3 more
- Hypoxic-hyperoxic preconditioning
- Placebo
- (no location specified)
May 6, 2022
Acute Myocardial Infarction, Ischemia-reperfusion Injury, Reperfusion Injury, Myocardial Trial in Santiago de Chile (Antioxidant
Recruiting
- Acute Myocardial Infarction
- +4 more
- Antioxidant formula
- Dextrose 5% in water
-
Santiago de Chile, ChileUniversity of Chile
Jan 17, 2022
Myocardial Ischemic-reperfusion Injury Trial (Remote Ischemic Conditioning (RIC))
Not yet recruiting
- Myocardial Ischemic-reperfusion Injury
- Remote Ischemic Conditioning (RIC)
- (no location specified)
Jan 28, 2022
Ischemia-Reperfusion Injury Trial in Nantong (dexmedetomidine, Placebo)
Recruiting
- Ischemia-Reperfusion Injury
- dexmedetomidine
- Placebo
-
Nantong, Jiangsu, ChinaAffiliated Hospital Nantong University
Oct 27, 2022
Vagus Nerve Stimulation, Acute Coronary Syndrome, Ischemia Reperfusion Injury Trial in Krasnodar (TENS)
Recruiting
- Vagus Nerve Stimulation
- +2 more
- TENS
-
Krasnodar, Russian FederationScientific Research Institute Ochapovsky Regional Clinical Hospi
Aug 7, 2023
Coronary Artery Bypass Grafting, Coronary Artery Disease Trial (Melatonin, )
Not yet recruiting
- Coronary Artery Bypass Grafting
- Coronary Artery Disease
- Melatonin
- placebo
- (no location specified)
Sep 21, 2022
STEMI, Remote Ischaemic Conditioning, Myocardial Reperfusion Injury Trial in Worldwide (Remote Ischaemic Conditioning (RIC),
Recruiting
- STEMI
- +2 more
- Remote Ischaemic Conditioning (RIC)
- Sham-control
-
Mombasa, Kenya
- +19 more
Nov 1, 2022
Ischemia Reperfusion Injury, Myocardial Injury, Acute Kidney Injury Trial in San Francisco (Niacinamide, Placebo)
Recruiting
- Ischemia Reperfusion Injury
- +2 more
- Niacinamide
- Placebo
-
San Francisco, CaliforniaKaiser Permanente San Francisco Medical Center
Jun 27, 2022
Myocardial Injury, Cardiac Surgery Trial in Jakarta (Cyclosporin, remote ischemic preconditioning, Placebo)
Completed
- Myocardial Injury
- Cardiac Surgery
- Cyclosporin
- +2 more
-
Jakarta, DKI Jakarta, IndonesiaIndonesia University
Jan 10, 2023
Cardiovascular Diseases Trial in Peking (cardiomyopeptidin)
Active, not recruiting
- Cardiovascular Diseases
-
Peking, Beijing, ChinaChinese People's Liberation Army General Hospital
Dec 1, 2023
STEMI, Large Thrombus Burden, No-Reflow Phenomenon Trial (Upfront preparation of microcirculation to minimize risks of no-reflow
Not yet recruiting
- STEMI
- +2 more
- Upfront preparation of microcirculation to minimize risks of no-reflow and reperfusion injury
- (no location specified)
May 26, 2022
Out of Hospital Cardiac Arrest, Inflammatory Response, Ischemia Reperfusion Injury Trial in Oslo (Targeted temperature
Completed
- Out of Hospital Cardiac Arrest
- +3 more
- Targeted temperature management
- Standard care, early treatment of fever
-
Oslo, NorwayOslo University Hospital
Sep 17, 2021
Ischemic Reperfusion Injury Trial (SMOFlipid, Normal saline 0.9%)
Not yet recruiting
- Ischemic Reperfusion Injury
- SMOFlipid
- Normal saline 0.9%
- (no location specified)
Jul 2, 2021
Optimized Cardioprotection Therapy in Obese Subjects With AMI
Unknown status
- Acute Myocardial Infarction
- +3 more
- PCI
-
Xi'an, Shaanxi, ChinaXijing hospital
Sep 25, 2020
Mer-TK in Human Cardiac Cells
Completed
- Myocardial Inflammation
- Myocardial Infarction
- Change in Soluble MER Concentration
-
Chicago, IllinoisAnn & Robert H Lurie Children's Hopsital
Aug 10, 2021
Myocardial Infarction Trial (WJ-MSC cells implantation, CTSTMD PBS without WJ-MSC, Conventional drug therapy)
Not yet recruiting
- Myocardial Infarction
- WJ-MSC cells implantation
- +2 more
- (no location specified)
Feb 18, 2021
Liver Ischemia-reperfusion Injury and Clinical Data Analysis
Recruiting
- Liver Injury
- No intervention
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Oct 6, 2023
Post-reperfusion Troponin
Recruiting
- Acute Myocardial Infarction
-
Indianapolis, IndianaIU Methodist Hospital
May 26, 2023
Ischemic Reperfusion Injury Trial in Shijiazhuang City (Dexmedetomidine, 0.9% Sodium chloride, Tourniquet(Early))
Recruiting
- Ischemic Reperfusion Injury
- Dexmedetomidine
- +3 more
-
Shijiazhuang City, Hebei, China
- +1 more
Dec 13, 2022